[Effect of radio-immunochemotherapy-using antiferritin antibody combined with anthracycline drugs on hepatocellular carcinoma cell].
Une
Y
Y
First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.
Sato
Y
Y
Alam
S
S
Nagabuchi
E
E
Hata
Y
Y
Uchino
J
J
D000906:Antibodies / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015251:Epirubicin / Q000627:therapeutic use; D005293:Ferritins / Q000276:immunology*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D014407:Tumor Cells, Cultured
D000906:Antibodies; D007457:Iodine Radioisotopes; D015251:Epirubicin; D004317:Doxorubicin; D005293:Ferritins; C027260:pirarubicin